PharmaTech

DECEMBER 14, 2022

Procipient ® (Dimethyl Sulfoxide USP, PhEur ) is the only compendial DMSO specifically for pharmaceutical use. Procipient is supported with the proper documentation required by pharmaceutical regulatory authorities.

Pharmaceutical 40

Pharmaceutical 40

PharmaTech

OCTOBER 21, 2022

Aragen’s new 12,000 ft² facility will include various dosage form capabilities, including oral solids, liquids, topicals, and films.

Manufacturing 40

Manufacturing 40

European Pharmaceutical Review

NOVEMBER 11, 2022

The paper suggested low bioavailability after topical ophthalmic administration is evidence of the need for more effective molecules, as well as formulations that target sites more precisely. Developments need to be made to enable lower dosages and toxicity, limit adverse effects and find better treatment efficacy of ocular drugs, it stated.

Pharmaceutical 95

Pharmaceutical Safety Medicine 95

Pharmaceutical Technology

APRIL 20, 2023

The facility complements the company’s current pharma innovation centres in France and Singapore, and intends to improve the patient experience with modern oral dosage forms. Situated at the hub of the country’s northeastern pharmaceutical corridor, the new facility is staffed by research, application and formulation specialists.

Pharmaceutical 52

Pharmaceutical Training Manufacturing Pharma 52

European Pharmaceutical Review

MARCH 28, 2023

Dosage for Otezla was 30mg twice daily. Nearly one-quarter of people with psoriasis have moderate to severe forms of the condition. Current therapies include topicals, orals and biologics. In both studies, Sotyktu was given as 6mg once daily compared to placebo.

Patients 95

Patients Medicine Medical Pharmaceutical 95

European Pharmaceutical Review

MARCH 10, 2023

Currently, effective topical administration is challenging as the industry aims to prolong drug residence time and guarantee appropriate ocular permeation. How to enhance ocular drug bioavailability One approach to enhance drug bioavailability after topical administration is increasing corneal permeability.

Side effects 81

Side effects Management Leads Safety 81

PM360

DECEMBER 14, 2023

A standard dose of the medicine causes acute kidney damage in 20% of patients and 50% of those who receive higher dosages used to treat life-threatening infections on a broad spectrum. The downside to this potent drug is it can be quite toxic and poses risks to the human body even in small doses.

Healthcare 52

Healthcare Healthcare FDA Education 52